Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Shares Outstanding (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Shares Outstanding for 16 consecutive years, with $19.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 3.5% to $19.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Dec 2025, up 3.5% year-over-year, with the annual reading at $19.8 million for FY2025, 3.5% up from the prior year.
  • Shares Outstanding hit $19.8 million in Q4 2025 for Ligand Pharmaceuticals, up from $19.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $19.8 million in Q4 2025 to a low of $16.7 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $17.8 million across 5 years, with a median of $17.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 1.1% in 2022 and later rose 8.83% in 2024.
  • Year by year, Shares Outstanding stood at $16.8 million in 2021, then increased by 1.1% to $17.0 million in 2022, then rose by 3.57% to $17.6 million in 2023, then grew by 8.83% to $19.1 million in 2024, then grew by 3.5% to $19.8 million in 2025.
  • Business Quant data shows Shares Outstanding for LGNDZ at $19.8 million in Q4 2025, $19.7 million in Q3 2025, and $19.4 million in Q2 2025.